CIK 0001001316 · Large accelerated filer
TG THERAPEUTICS, INC.
Sign in to watch- Ticker
- TGTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 363898269
- Phone
- (212) 554-4484
- Business address
- 2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY, 10014
- Former names
- MANHATTAN PHARMACEUTICALS INC, ATLANTIC TECHNOLOGY VENTURES INC, ATLANTIC PHARMACEUTICALS INC
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Material agreement · Other events
- D/A Other Amended Notice of Exempt Offering of Securities
- D/A Other Amended Notice of Exempt Offering of Securities
- 8-K Event Material agreement · Other events
- 8-K/A Event Executive or director change
- SC 13D/A Stake Beneficial Ownership Report
- SC 13D Stake Beneficial Ownership Report
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 8-K Event Material agreement · Acquisition or sale completed · Executive or director change · Bylaws or fiscal year change · Other events
- 8-K Event Material agreement
- 8-K Event Material agreement
- 10-Q Report Quarterly Report
- 8-K Event Material agreement
- 10-Q/A Report 10-Q/A
- 10-Q Report Quarterly Report
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Executive or director change · Bylaws or fiscal year change
Page 31 of 58 · 1,151 filings